BIOAGE raises $23M to scale AI-driven platform to discover and develop drugs that treat aging
<p>BIOAGE was founded to develop therapies that extend human lifespan because we are convinced this is the most powerful way to address the chronic diseases of aging. Your risk of getting — and dying from — heart disease, Alzheimer’s, cancer, diabetes, and other diseases rises precipitously with age. The current approach of treating these diseases one at a time is not effective. For most individual patients, the last two decades of life are typically spent managing multiple debilitating chronic diseases. This results in poor quality of life and an unmanageable<strong> </strong>economic burden for the healthcare system as a whole. This is why treating aging directly can transform the future of healthcare. Science has confirmed that there are interventions and targets that positively impact multiple chronic diseases by influencing fundamental processes of aging; it follows that working on these will deliver higher impact for human health.</p>
<p><a href="https://medium.com/@BioAge/bioage-raises-23m-to-scale-ai-driven-platform-to-discover-and-develop-drugs-that-treat-aging-176eaed36efa"><strong>Click Here</strong></a></p>